Apollo Hospitals Enterprise share price
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹7,604.50.
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,11,146 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 53.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 11.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 4,96,46046.0% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 12 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹7,044 Crup 6.63%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹610 Crup 10.72%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 8.7%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 7 Nov | Dec 2024Filed 11 Feb | Mar 2025Filed 13 Jun | Jun 2025Filed 12 Aug | Sep 2025Filed 6 Nov | Dec 2025Filed 10 Feb | Mar 2026Filed 20 May | Jun 2026Filed 12 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 | 7,044 |
| Net profit | 396 | 379 | 415 | 441 | 494 | 516 | 551 | 610 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 7.1% | 6.9% | 7.4% | 7.5% | 7.8% | 8.0% | 8.3% | 8.7% |
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Healthcare servicesHealthcare services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹12,750 Crup 13.64%50.1%
- Digital health & pharmacy distributionDigital health & pharmacy distribution, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹10,808 Crup 18.86%42.5%
- Retail health and diagnosticsRetail health and diagnostics, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1,865 Crup 20.07%7.3%
- OthersOthers, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹5 Cr0.0%
Valuation
Today, against the company's own history.PE ratio and valuation history
At or below today's level on 6% of 2,287 trading days over the last 10 years.
At or below today's level on 49% of 1,968 trading days since Nov 2018.
At or below today's level on 29% of 1,968 trading days since Nov 2018.
At or below today's level on 44% of 2,477 trading days over the last 10 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +12.4% | +34.3% | −16.5% | 0.3% |
| 3 years | +20.1% | +33.3% | −10.1% | 0.3% |
| 5 years | +20.9% | +65.9% | −27.3% | 0.3% |
Mutual funds holding it
401 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 164 of the 231 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 5 more funds filed their first portfolio on record, holding it.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 9
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 8
- AddedAdded. Funds that held more shares than at the end of the month before.
- 120
- CutCut. Funds that held fewer shares than at the end of the month before.
- 111
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 148
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end.
- 11
| Fund | |||
|---|---|---|---|
 SBI Nifty 50 ETFSBI Mutual Fund | 19,96,066 | 0.80% | ₹1,629.9 Cr |
 HDFC Flexi Cap FundHDFC Mutual Fund | 10,54,093 | 0.79% | ₹860.7 Cr |
 Axis Large Cap FundAxis Mutual Fund | 10,40,646 | 2.91% | ₹849.7 Cr |
 ICICI Prudential Balanced Advantage FundICICI Prudential Mutual Fund | 6,97,048 | 0.79% | ₹569.2 Cr |
 UTI Nifty 50 ETFUTI Mutual Fund | 6,84,525 | 0.80% | ₹558.9 Cr |
| Axis Focused FundAxis Mutual Fund | 6,49,263 | 5.06% | ₹530.2 Cr |
 Nippon India ETF Nifty 50 BeESNippon India Mutual Fund | 6,40,774 | 0.80% | ₹523.2 Cr |
| SBI Flexicap FundSBI Mutual Fund | 5,65,751 | 2.09% | ₹462.0 Cr |
 Franklin India Flexi Cap FundFranklin Templeton Mutual Fund | 5,62,115 | 2.52% | ₹459.0 Cr |
| Nippon India Pharma FundNippon India Mutual Fund | 5,48,795 | 4.89% | ₹448.1 Cr |
Peers and competitors
Hospital, 38 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Apollo Hospitals Enterprise in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Manipal Health EnterprisesMANIPALHOS | 79,889 | – | – | – | – | – | – | – | 0.00% |
 Max Healthcare InstituteMAXHEALTH | 79,325 | 54.4 | 7.4 | 35.4 | +16.0% | +27.0% | 14.5% | 13.0% | 0.25% |
 Aster DM Quality CareASTERDM | 56,201 | 176.4 | – | – | +15.7% | +0.2% | 8.0% | 12.4% | 0.47% |
 Fortis HealthcareFORTIS | 53,821 | 51.4 | 5.4 | 26.3 | +17.5% | +20.7% | 11.1% | 12.7% | 0.14% |
 Narayana HrudayalayaNH | 33,656 | 41.2 | 7.4 | 20.8 | +57.8% | +3.9% | 20.0% | 13.1% | 0.27% |
 Global HealthMEDANTA | 31,862 | 57.3 | 8.0 | 32.6 | +21.3% | +4.1% | 15.1% | 14.2% | 0.04% |
 Krishna Institute of Medical SciencesKIMS | 27,937 | 136.6 | 12.4 | 37.4 | +30.9% | −46.2% | 9.3% | 8.7% | 0.00% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,024 | 101.3 | 7.4 | 24.6 | – | – | 7.6% | 14.1% | 0.00% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.| Ex-date | Type | Per share |
|---|---|---|
| 14 Aug 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹10.00 |
| 16 Feb 2026 | Interim | ₹10.00 |
| 19 Aug 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹10.00 |
| 14 Feb 2025 | Interim | ₹9.00 |
| 16 Aug 2024 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹10.00 |
| 20 Feb 2024 | Interim | ₹6.00 |
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
15 Oct · Analysts
Sep 2026
Aug 2026
Apollo Hospitals Enterprise share price by year
Each calendar year to 2025.Apollo Hospitals Enterprise share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 7,042.50 | −3.5% | 8,012.00 | 6,052.60 |
| 2024 | 7,296.35 | +27.9% | 7,424.85 | 5,682.00 |
| 2023 | 5,704.10 | +27.4% | 5,760.50 | 4,200.95 |
| 2022 | 4,477.60 | −10.7% | 5,065.25 | 3,524.30 |
| 2021 | 5,013.40 | +107.8% | 5,733.95 | 2,409.25 |
| 2020 | 2,412.80 | +67.3% | 2,463.00 | 1,088.85 |
| 2019 | 1,442.00 | +14.6% | 1,536.80 | 1,116.40 |
| 2018 | 1,258.30 | +4.4% | 1,292.20 | 927.10 |
| 2017 | 1,204.80 | +2.1% | 1,352.50 | 985.95 |
| 2016 | 1,179.90 | −19.5% | 1,498.40 | 1,126.00 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 7,600.00 | 7,740.00 | 7,550.00 | 7,730.00 | 7,655.53 | 4,96,460 | 46.0% |
| 22 Oct 2026 | 7,505.00 | 7,648.00 | 7,465.00 | 7,604.50 | 7,580.55 | 4,18,903 | 57.3% |
| 21 Oct 2026 | 7,750.00 | 7,780.00 | 7,560.00 | 7,600.00 | 7,622.37 | 2,66,377 | 60.9% |
| 19 Oct 2026 | 7,880.50 | 7,895.00 | 7,664.50 | 7,700.00 | 7,747.27 | 4,22,465 | 61.9% |
| 16 Oct 2026 | 7,928.00 | 7,928.00 | 7,795.00 | 7,890.00 | 7,849.01 | 5,47,599 | 69.8% |
| 15 Oct 2026 | 7,812.00 | 7,966.50 | 7,767.50 | 7,889.50 | 7,898.16 | 4,39,956 | 57.1% |
| 14 Oct 2026 | 7,825.50 | 7,889.50 | 7,697.00 | 7,824.00 | 7,822.81 | 5,46,866 | 58.1% |
| 13 Oct 2026 | 7,775.00 | 7,924.00 | 7,688.00 | 7,871.00 | 7,845.61 | 4,72,066 | 50.7% |
| 12 Oct 2026 | 8,028.50 | 8,100.00 | 7,759.00 | 7,775.00 | 7,984.02 | 9,90,813 | 63.0% |
| 9 Oct 2026 | 7,950.00 | 8,027.50 | 7,775.50 | 8,027.50 | 7,919.69 | 14,49,612 | 52.4% |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 2 Sep 2010 | Split | 0.5000 | Each share became 2. |
About Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Limited runs hospitals, pharmacies, diagnostic centres and clinics, and a digital health platform. Its customers are patients who need hospital care, buy medicines, take tests or consult doctors online. The business has three parts. Healthcare Services is the hospital network, with centres of excellence in cardiology, oncology, neurology and orthopaedics. Apollo HealthCo, a subsidiary, runs the Apollo Pharmacy network and the Apollo 24|7 digital platform. Apollo Health and Lifestyle Limited, a wholly owned subsidiary, covers diagnostics and care outside hospitals: primary care, dialysis, dental and diabetes clinics, short-stay surgery, and maternity and fertility services.
The company has more than 70 hospitals with over 10,000 beds, in cities including Chennai, Hyderabad, Bengaluru, Kolkata, Delhi, Mumbai and Ahmedabad. Its network also includes more than 7,000 pharmacies and more than 2,500 diagnostic centres. Patients from over 150 countries have been treated at its hospitals. Its registered office is in Chennai.
Apollo Hospitals was founded in 1983 by Dr Prathap C. Reddy. In the year to March 2026 the company acquired the shares held by other investors in Apollo Health and Lifestyle, which became a wholly owned subsidiary. On 30 June 2025 its board approved a scheme of arrangement to demerge its pharmacy distribution and Apollo 24|7 businesses into a separate company. Shareholders approved the scheme on 24 June 2026, and it needs approval from the National Company Law Tribunal.
Its promoter includes the family of Dr Prathap C. Reddy, who is also its Executive Chairman. A promoter is the person or group that set up a company or controls it. Four of his daughters, Preetha Reddy, Suneeta Reddy, Shobana Kamineni and Sangita Reddy, are directors.
- Legal name
- Apollo Hospitals Enterprise Limited
- NSE symbol
- APOLLOHOSP
- BSE code
- 508869
- ISIN
- INE437A01024
- Industry
- Healthcare Services
- Listed
- Mar 1983 on BSE, Jan 1996 on NSE
- Face value
- ₹5
- CIN
- L85110TN1979PLC008035
- Corporate identity number, the registrar of companies' code for it